FGFR2 and breast cancer: Several authors have reported the occurrence of single nucleotide polymorphisms (SNPs) in FGFR2 as a risk factor for breast cancer in women and the study of their expression with prognostic value in relation to survival and disease-free period, and its increased expression is associated with poor clinical outcome [52, 53, 54].